FEBS Letters · 1999 · 82 citations · 35 references
MedicineBiochemistryPharmacologyBioisosterismNeuropharmacologyPharmacodynamicsLipid MetabolismPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAntiplatelet DrugsArachidonic Acid MetabolitesArachidonic Acid SignalingLipoxygenase InactivationLipoxygenase PathwayNitric OxidePlatelet MetabolismPlatelet Responses To Agonists
Anandamide (arachidonoylethanolamide, AnNH) is shown to activate human platelets, a process which was not inhibited by acetylsalicylic acid (aspirin). Unlike AnNH, hydroperoxides generated thereof by lipoxygenase activity, and the congener (13-hydroxy)linoleoylethanolamide, were unable to activate platelets, though they counteracted AnNH-mediated stimulation. On the other hand, palmitoylethanolamide neither activated human platelets nor blocked the AnNH effects. AnNH inactivation by human platelets was afforded by a high-affinity transporter, which was activated by nitric oxide-donors up to 225% of the control. The internalized AnNH could thus be hydrolyzed by a fatty acid amide hydrolase (FAAH), characterized here for the first time.
35
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
William A. Devane, Aviva Breuer, Roger G. Pertwee et al. · Science · 1992 · 5.6K citations
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
G. V. R. Born · Nature · 1962 · 4.3K citations
Medicine, Biochemistry, Hematology +14
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse et al. · Nature · 1996 · 1.9K citations
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Vincenzo Di Marzo, Angelo Fontana, Hugues Cadas et al. · Nature · 1994 · 1.6K citations · Full text
Control of pain initiation by endogenous cannabinoids
Antonio Calignano, Giovanna La Rana, Andrea Giuffrida et al. · Nature · 1998 · 1.1K citations
Medicine, Neurobiology, Pharmacology +14